216.73.216.127
dgid:
enl:
npi:0
/nas/content/live/oph360live/wp-content/themes/rd360/archive.php
-Advertisement-
Home PHOTON trial assesses aflibercept 8 mg for diabetic macular edema

Video

Patients with neovascular AMD who experience rapid fluid resolution with aflibercept 8 mg maintain long-term dosing intervals

Watch Now
By rd360stg
Is My Practice Interventional? The Importance of a Practice Assessment
By rd360stg
Learn about a drop to treat acute infectious conjunctivitis
By rd360stg
Tecnis Eyhance leads to good visual and refractive outcomes in post-refractive surgery eyes
By rd360stg
VERONA 24-week results: efficacy of vorolanib intravitreal insert in DME
By rd360stg
AMD updates from ARVO: treatment burden, ongoing assessment of vorolanib intravitreal insert
By rd360stg
Costs, access are important considerations for dry eye treatment
By rd360stg
Ocubio launches qualified autologous serum eye drops
By rd360stg
Updates from the field: nearly 1-year post-launch of Lacrifill for dry eye disease
By rd360stg
What you need to know about the OmniVu IOL
By rd360stg
Updates on education and offerings from the Ophthalmology Foundation
By rd360stg
Cyclosporine 0.09% can quickly improve ocular surface health in dry eye patients
By rd360stg
Who is the ideal candidate for EVO ICL?
-Advertisement-
-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899
[email protected]

Social Links

© 2025 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-